JLABS @ Washington, DC Children's QuickFire Challenge
In honor of the new JLABS @ Washington, DC – a 32,000 square foot facility located on the new Children’s National Research and Innovation Campus from Johnson & Johnson Innovation, LLC in partnership with Children’s National Health System (“Children’s National”) - Johnson & Johnson Innovation – JLABS announces the JLABS @ Washington, DC Children’s QuickFire Challenge.
Visionaries within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in grant funding; one year of residency at JLABS @ Washington, DC with the use of a bench, workstation, and access to the JLABS @ Washington, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies.
Johnson & Johnson Innovation is proud to be among those answering the call to prioritize pediatric care, a message widely celebrated at the 2018 State of the Union address alongside the promise of an additional $500 million in government funding for pediatric oncology research over the next 10 years.
In addition to welcoming the awardees in this QuickFire Challenge upon opening in 2020, JLABS @ Washington, DC offers residency to pharmaceutical, medical device, consumer and health technology companies that are aiming to advance the development of new drugs, medical devices, precision diagnostics and health technologies.
Rewards and benefits:
- Up to $150,000 in total grant funding*
- One year of residency at JLABS @ Washington, DC with the use of a bench, workstation and access to the JLABS @ Washington, DC community for one year
- Mentoring by the Johnson & Johnson Family of Companies
 The contracting entity is Children’s National at Walter Reed, LLC, a wholly owned subsidiary of Children’s National Health System.